CereSpir Incorporated and the National Neuroscience Institute Singapore Announce Positive Data Showing Beneficial Effects of CereSpir’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease

NEW YORK and SINGAPORE, Dec. 10 (Korea Bizwire) — CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative diseases, and THE NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE, a national and international center of excellence in neuroscience with its mission to improve lives through integrated clinical service, research [...]